Subscribe to unlock this article
Thanks for your support.
Vienna-based SF Lacus Legacy, founded by Paul Szyszkowitz, former Bain consultant, and Christoph Siegesleuthner, former private equity professional at Rothschild & Lyvia Group, has acquired 100% of Pharmacom Handels GmbH and Binder Pharmaservices GmbH.
The two companies are leading providers of specialized pharmaceutical distribution (Direct-to-Pharmacy, DTP), data insights and medicine tracking services to blue-chip pharmaceutical clients in Austria, supported by proprietary software solutions.
The acquisition was financed with the backing of a strong group of investors including Istria Capital, JB46, TTCER Partners, Alza Capital Partners, Evolutiq, RP Global, Cromwell Harbor, Lineage, Scipio Swanlaab, Ambit Partners, among others. UniCredit Bank Austria provided debt financing at more than 4.0x leverage, underscoring the scale and confidence in the transaction.
Pharmacom and Binder are critical players in Austria’s pharmaceutical sector. With revenues in the hundreds of millions, they distribute a significant share of high-priced medicines across the country. The group was acquired at an enterprise value in the mid-double-digit millions. Their lean, technology-native platform enables substantial efficiency gains across operations.
“Pharmacom and Binder have convinced us with their unique position in creating value for both blue-chip pharma suppliers and the Austrian healthcare system,” said Christoph Siegesleuthner. “Their proprietary technology enhances data insights and medicine tracking, prevents supply shortages and drives operational efficiency. With a strong tech DNA and well-established processes, Pharmacom and Binder require only about 25% of the headcount needed by comparable companies, while their skilled team and IT resources routinely identify errors by doctors and pharmacies, helping protect patients’ health.
“We also see significant potential to expand this proven model into other European and related markets facing similar challenges to Austria.” added Paul Szyszkowitz.
Legal: Polak & Partner and Schoenherr / Financial DD: TPA / Regulatory Approval: Herbst Kinsky / Debt Advisory: Tech Credit Partners
